ClinicalTrials.gg
Drug

Dipyrone clinical trials

Also written Metamizole.

studies test it
24
open now
6
in phase 3
4
first study started
1998

How each study uses Dipyrone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Dipyrone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dipyrone
7
OPTALGIN
2

Other names

Metamizole
10
Metamizol
3
Novalgin
2
Metamizole Sodium
1

Studies by the year they started

24 studies that test it; most in 2016 (3)

Studies that test Dipyrone, by start year
YearStudies
19982
20041
20061
20071
20091
20102
20141
20163
20171
20182
20192
20201
20211
20253
20262

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
3
Phase 3
4
Phase 4
7
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 20

University Hospital, Basel, Switzerland (5) · Medical University of Silesia (3) · Jessa Hospital (2) · Boehringer Ingelheim (2) · Wolfson Medical Center (2) · University Children's Hospital Basel (1) · Baskent University (1) · University Center of Araraquara (1)

Often tested with

Tested in the same studies.

Acetaminophen (7) · Ibuprofen (4) · Lidocaine (1) · Proxymetacaine (1) · Pain Therapy (1) · Dexketoprofen (1) · Papaverine (1) · Diclofenac hydroxyethylpyrrolidine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Dipyrone, phase 3 first.

Studies

Open first, then newest update. How each study uses Dipyrone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 24

See all 24 studies that test Dipyrone →

Given beside what is tested · 15 — Dipyrone is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with Dipyrone

Codes

What other systems call Dipyrone · ClinicalTrials.gg INT007382

  • MeSH (NLM) D004177DipyroneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 6429L0L52YDIPYRONEConfirmed FDA, NLM
  • RxNorm 3523One source FDA
  • NCI Thesaurus C65435DipyroneOne source FDA

Also registered as metamizole (UNII 934T64RMNJ · RxNorm 3523) and metamizole sodium (UNII VSU62Z74ON · RxNorm 1537943).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.